Key Record Dates
ClinicalTrials.gov Identifier: | NCT05315713 |
---|---|
Brief Title: | An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma |
First Submitted : | March 31, 2022 |
First Submitted that Met QC Criteria : | March 31, 2022 |
First Posted : | April 7, 2022 |
Last Update Submitted that Met QC Criteria : | April 27, 2023 |
Last Update Posted : | April 28, 2023 |